Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview
CU Correll, E Kim, JK Sliwa, W Hamm, S Gopal… - CNS drugs, 2021 - Springer
The availability of long-acting injectable (LAI) antipsychotics for the treatment of
schizophrenia provides clinicians with options that deliver continuous drug exposure and …
schizophrenia provides clinicians with options that deliver continuous drug exposure and …
[HTML][HTML] Lipid based intramuscular long-acting injectables: Current state of the art
J Wilkinson, D Ajulo, V Tamburrini, G Le Gall… - European Journal of …, 2022 - Elsevier
Long acting injectables (LAI) have received increased research and commercial interest due
to their potential for improving treatment effectiveness and adherence for antipsychotic …
to their potential for improving treatment effectiveness and adherence for antipsychotic …
Fundamental understanding of drug absorption from a parenteral oil depot
RW Kalicharan, P Schot, H Vromans - European Journal of Pharmaceutical …, 2016 - Elsevier
Oil depots are parenteral drug formulations meant for sustained release of lipophilic
compounds. Until now, a comprehensive understanding of the mechanism of drug …
compounds. Until now, a comprehensive understanding of the mechanism of drug …
Alcohol abuse in chronic schizophrenics: implications for management in the community
SD Soni, M Brownlee - Acta Psychiatrica Scandinavica, 1991 - Wiley Online Library
This study was designed to investigate the effects of regular alcohol consumption on chronic
schizophrenic patients maintained on fluphenazine decanoate in the community. A group of …
schizophrenic patients maintained on fluphenazine decanoate in the community. A group of …
Spatial distribution of oil depots monitored in human muscle using MRI
RW Kalicharan, P Baron, C Oussoren… - International Journal of …, 2016 - Elsevier
Oil depots are parenteral drug formulations meant for sustained release of lipophilic
compounds. According to mass transport models, the drug-release rate from these injections …
compounds. According to mass transport models, the drug-release rate from these injections …
Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots
M Probst, JP Kühn, E Scheuch, A Seidlitz… - Journal of Controlled …, 2016 - Elsevier
The present pilot study introduces a method that might give novel insights in drug absorption
processes from intramuscularly administered depots. An oily suspension or an aqueous …
processes from intramuscularly administered depots. An oily suspension or an aqueous …
Where does hydrolysis of nandrolone decanoate occur in the human body after release from an oil depot?
RW Kalicharan, MR Bout, C Oussoren… - International journal of …, 2016 - Elsevier
Long-term therapy of nandrolone (N) is recommended to increase mineral density and
muscle strength. Using a parenteral sustained release drug formulation with nandrolone …
muscle strength. Using a parenteral sustained release drug formulation with nandrolone …
Long-acting injectable antipsychotics and the management of nonadherence
We assume that the reader is familiar with antipsychotic maintenance treatment, as well as
some of the current practice guidelines for LAI use. 1-3 Such practice is often misguided in …
some of the current practice guidelines for LAI use. 1-3 Such practice is often misguided in …
Anatomy and physiology of the injection site: implications for extended release parenteral systems
A McDowell, NJ Medlicott - Long acting injections and implants, 2011 - Springer
Understanding how the biological environment contributes to drug release following
administration is increasingly becoming a focus for drug delivery research. Achieving …
administration is increasingly becoming a focus for drug delivery research. Achieving …
In vitro simulation of distribution processes following intramuscular injection
M Probst, M Schmidt, W Weitschies… - Current Directions in …, 2016 - degruyter.com
There is an urgent need for in vitro dissolution test setups for intramuscularly applied dosage
forms. Especially biorelevant methods are needed to predict the in vivo behavior of newly …
forms. Especially biorelevant methods are needed to predict the in vivo behavior of newly …